Tweets
Can computers tell the difference between RA & PsA?
Dr. David Liew ( @drdavidliew) discusses Abstract 0242 presented at #ACR22. Abstract 0242: Neural Networks for Distinguishing RA from PsA by Using Magnetic Resonance Imaging
https://t.co/ZL5TYIdT6Q https://t.co/tZWIAl0rb0
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Upadacitinib vs Adalimumab in PsA using RAPID3
Dr. Catherine Sims ( @DrCassySims) discusses abstract 0192 presented at #ACR22. 0192: Upadacitinib versus Adalimumab on Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with PsA,
https://t.co/nRjgM45GdO https://t.co/MDqpW7ACXa
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
#ACR22 Rheumatology Roundup w/ Drs. Kavanaugh & Cush
#1044 Combo Rx SpA
#0533 CCP spit
#1604 StopRA
#2251 Tofa & RA ILD
#0420 NSAID SpA
#002 CA in IIM
#0113 BTK Sjogrens
#L05 Prolia EOA
#0526 Pexivas
#1106 TCZ PMR
Video: https://t.co/JG3spEsYDD
Podcast: https://t.co/nbmeiGo2yt https://t.co/E7RDPTFsaS
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Urinary Biomarkers in Lupus
Dr.Cush interviews Dr. Fava about Abstract 536 at #ACR22. Abstract 0536: Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria
https://t.co/3IfPdTMufb https://t.co/XVECG9mJri
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Social Media in Academic Rheumatology
Dr. Kathryn Dao and Jorena Lim discuss the impact of social media in rheumatology. @KDAO2011
https://t.co/a6yoH745Ap https://t.co/RioB7n9fWZ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Dual target blockade may be better than one in SLE
Dr. Yusof ( @Yuz6Yusof) discusses abstracts #L07 and #1001 presented at #ACR22.
https://t.co/20MGDHBLT1 https://t.co/4IcBKn1IKg
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Repetitive Testing of Anti-dsDNA Antibodies May Predict Flares in SLE
Dr. Sheila Reyes ( @RHEUMarampa ) summarizes abstract #0327 presented during the poster session at #ACR22.
https://t.co/kSFfyRIQXZ https://t.co/bVTE9VsFmC
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Poor Medication Adherence in SLE and How to Improve It
Dr. Janet Pope ( @Janetbirdope) discusses three abstracts presented at #ACR22.
https://t.co/AWxj4fsTkt https://t.co/Lol1zG7C0q
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
2022 ACR/EULAR Classification Criteria for GCA
Dr. Michael Putman discusses interesting take-home messages from the Vasculitis Investigators Meeting at ACR22 Convergence regarding the 2022 ACR/EULAR Classification Criteria for GCA.
https://t.co/w7NE2Wpm95 https://t.co/vB94wS7ONF
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
To Beta Block or Not in GCA & Large Vessel Vasculitis
Dr. Harkins ( @DrTrishHarkins) discusses abstract 0477 presented at #ACR22.
Abstract 0477: Can Beta-blockers Prevent Aortic Dilation in Patients w/ Giant Cell Arteritis & Large Vessel Vasculitis?
https://t.co/cwA1Z5XrQr https://t.co/QGSS6RUBn3
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Avoid Abatacept in RA patients with a history of cancer?
Dr. Richard Conway ( @RichardPAConway ) discusses abstracts #0267 and #0255 presented at #ACR22.
https://t.co/t8hun1qfnJ https://t.co/UpuWkk7k3x
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Professor Georg Schett, MD (University of Erlangen-Nuremberg) presents his novel study of CAR-T cells therapy in Lupus - A MUST look! #ACR22
ACR 2022: CAR-T Cell Treatment of Refractory SLE | VuMedi https://t.co/cpJShTvQDy via @vumedi
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
